Table 3.
Multivariate analysis between clinical characteristics and pCR.
| Variable | OR | CI (95%) | P |
|---|---|---|---|
| Hormone receptors | |||
| ER+/PR+ | Ref. | Ref. | Ref. |
| ER+/PR- | 1.334 | 0.404-4.403 | 0.636 |
| ER-/PR- | 3.941 | 1.772-8.766 | 0.001 |
| HER2 | |||
| Negative | Ref. | Ref. | Ref. |
| Positive | 1.545 | 0.770-3.099 | 0.221 |
| Ki67(%) | |||
| ≤14 | Ref. | Ref. | Ref. |
| >14 | 2.395 | 0.962-5.962 | 0.061 |
| MetS status | |||
| No | Ref. | Ref. | Ref. |
| Yes | 0.316 | 0.113-0.886 | 0.028 |
pCR, pathologic complete response; OR, odds ratio; CI, confidence interval; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; MetS, metabolic syndrome.